Your browser doesn't support javascript.
loading
[HVPG minimally invasive era: exploration based on forearm venous approach].
Wang, J T; Li, L; Niu, M; Zhu, Q L; Zhao, Z W; Kotani, K; Yamamoto, A; Zhang, H J; Li, S X; Xu, D; Kang, N; Li, X G; Zhang, K P; Sun, J; Wu, F Z; Zhang, H L; Liu, D X; Lyu, M H; Ji, J S; Kawada, N; Xu, K; Qi, X L.
Afiliación
  • Wang JT; Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China.
  • Li L; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Niu M; Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China.
  • Zhu QL; Department of Gastroenterology, Affiliated Hospital of Southwest Medical University, Lanzhou 646000, China.
  • Zhao ZW; Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China.
  • Kotani K; Department of Hepatology, Osaka Municipal University Hospital, Osaka City, Japan.
  • Yamamoto A; Department of Interventional Radiology, Faculty of Medicine, Osaka City University, Osaka City, Japan.
  • Zhang HJ; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Li SX; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Xu D; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Kang N; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Li XG; Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Zhang KP; Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China.
  • Sun J; Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China.
  • Wu FZ; Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China.
  • Zhang HL; Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China.
  • Liu DX; Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China.
  • Lyu MH; Department of Gastroenterology, Affiliated Hospital of Southwest Medical University, Lanzhou 646000, China.
  • Ji JS; Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China.
  • Kawada N; Department of Hepatology, Osaka Municipal University Hospital, Osaka City, Japan.
  • Xu K; Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China.
  • Qi XL; Portal Hypertension Centers, Southeast University Affiliated Zhongda Hospital, Nanjing 210009,China.
Zhonghua Gan Zang Bing Za Zhi ; 32(1): 35-39, 2024 Jan 20.
Article en Zh | MEDLINE | ID: mdl-38320789
ABSTRACT

Objective:

The transjugular or transfemoral approach is used as a common method for hepatic venous pressure gradient (HVPG) measurement in current practice. This study aims to confirm the safety and effectiveness of measuring HVPG via the forearm venous approach.

Methods:

Prospective recruitment was conducted for patients with cirrhosis who underwent HVPG measurement via the forearm venous approach at six hospitals in China and Japan from September 2020 to December 2020. Patients' clinical baseline information and HVPG measurement data were collected. The right median cubital vein or basilic vein approach for all enrolled patients was selected. The HVPG standard process was used to measure pressure. Research data were analyzed using SPSS 22.0 statistical software. Quantitative data were used to represent medians (interquartile ranges), while qualitative data were used to represent frequency and rates. The correlation between two sets of data was analyzed using Pearson correlation analysis.

Results:

A total of 43 cases were enrolled in this study. Of these, 41 (95.3%) successfully underwent HVPG measurement via the forearm venous approach. None of the patients had any serious complications. The median operation time for HVPG detection via forearm vein was 18.0 minutes (12.3~38.8 minutes). This study confirmed that HVPG was positively closely related to Child-Pugh score (r = 0.47, P = 0.002), albumin-bilirubin score (r = 0.37, P = 0.001), Lok index (r = 0.36, P = 0.02), liver stiffness (r = 0.58, P = 0.01), and spleen stiffness (r = 0.77, P = 0.01), while negatively correlated with albumin (r = -0.42, P = 0.006).

Conclusion:

The results of this multi-centre retrospective study suggest that HVPG measurement via the forearm venous approach is safe and feasible.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipertensión Portal Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipertensión Portal Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China